New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin‐naïve people with type 2 diabetes on oral glucose‐lowering drugs: a randomized controlled trial (EDITION 3)-Reference-Cited by-同舟云学术

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin‐naïve people with type 2 diabetes on oral glucose‐lowering drugs: a randomized controlled trial (EDITION 3)

Published:2015-02-12 Issue:4 Volume:17 Page:386-394
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bolli G. B.¹,Riddle M. C.²,Bergenstal R. M.³,Ziemen M.⁴,Sestakauskas K.⁵,Goyeau H.⁶,Home P. D.⁷,

Affiliation:

1. Department of Medicine Perugia University Medical School, Hospital Santa Maria della Misericordia Perugia Italy

2. Department of Medicine Oregon Health & Science University Portland OR USA

3. International Diabetes Center at Park Nicollet Minneapolis MN USA

4. Sanofi‐Aventis Deutschland GmbH Frankfurt am Main Germany

5. Sanofi Chilly Mazarin France

6. EXPERIS IT Nanterre France

7. Institute of Cellular Medicine Newcastle University Newcastle upon Tyne UK

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12438

Reference25 articles.

1. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

2. Psychological Insulin Resistance in Patients With Type 2 Diabetes

3. Factors Associated With Psychological Insulin Resistance in Individuals With Type 2 Diabetes

4. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

5. Barriers to insulin initiation and intensification and how to overcome them

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: The INITIATION study;Diabetes, Obesity and Metabolism;2024-07-29

2. Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials;Diabetes, Obesity and Metabolism;2024-07

3. Ensuring patient safety when managing concentrated insulin glargine and insulin degludec at hospital admission;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2024-07

4. Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis;Diabetes Therapy;2024-06-15

5. Recent Progress in Glucose-Responsive Insulin;Diabetes;2024-06-10